Phase I Study of LB-100 With Docetaxel in Solid Tumors
Clinical trial NCT01837667 · COMPLETED
Trial details
- NCT number
- NCT01837667
- Sponsor
- Lixte Biotechnology Holdings, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.